Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-07-25

Clinical Trial Update: Use of Indocyanine Green in Robotic Prostate Surgeries [Phase 4]

View source ↗

Summary

Phase 4 trial update on using indocyanine green in robotic prostate surgeries, with conditions including prostate cancer adenocarcinoma and erectile dysfunction…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Indocyanine Green (Indocyanine Green)

Snippet

Sponsor: Ankara University | Conditions: Prostate Cancer Adenocarcinoma, Erectile Dysfunction Following Radical Prostatectomy | Phase 4 | Status: UNKNOWN